Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers.

Gonzalo-Gil E, Ikediobi U, Sutton RE.

Yale J Biol Med. 2017 Jun 23;90(2):245-259. eCollection 2017 Jun. Review.

2.
3.

Immunotherapy with an HIV-DNA Vaccine in Children and Adults.

Palma P, Gudmundsdotter L, Finocchi A, Eriksson LE, Mora N, Santilli V, Aquilani A, Manno EC, Zangari P, Romiti ML, Montesano C, Grifoni A, Brave A, Ljungberg K, Blomberg P, Bernardi S, Sandström E, Hejdeman B, Rossi P, Wahren B.

Vaccines (Basel). 2014 Jul 17;2(3):563-80. doi: 10.3390/vaccines2030563.

4.

IFNγ⁻TNFα⁻IL2⁻MIP1α⁻CD107a⁺PRF1⁺ CD8 pp65-Specific T-Cell Response Is Independently Associated With Time to Death in Elderly Humans.

Ferrando-Martínez S, Ruiz-Mateos E, Casazza JP, de Pablo-Bernal RS, Dominguez-Molina B, Muñoz-Fernández MÁ, Delgado J, de la Rosa R, Solana R, Koup RA, Leal M.

J Gerontol A Biol Sci Med Sci. 2015 Oct;70(10):1210-8. doi: 10.1093/gerona/glu171. Epub 2014 Sep 18.

5.

Early skewed distribution of total and HIV-specific CD8+ T-cell memory phenotypes during primary HIV infection is related to reduced antiviral activity and faster disease progression.

Ghiglione Y, Falivene J, Ruiz MJ, Laufer N, Socías ME, Cahn P, Giavedoni L, Sued O, Gherardi MM, Salomón H, Turk G.

PLoS One. 2014 Aug 5;9(8):e104235. doi: 10.1371/journal.pone.0104235. eCollection 2014.

6.

Therapeutic DNA vaccination of vertically HIV-infected children: report of the first pediatric randomised trial (PEDVAC).

Palma P, Romiti ML, Montesano C, Santilli V, Mora N, Aquilani A, Dispinseri S, Tchidjou HK, Montano M, Eriksson LE, Baldassari S, Bernardi S, Scarlatti G, Wahren B, Rossi P.

PLoS One. 2013 Nov 28;8(11):e79957. doi: 10.1371/journal.pone.0079957. eCollection 2013.

7.

Priming with recombinant auxotrophic BCG expressing HIV-1 Gag, RT and Gp120 and boosting with recombinant MVA induces a robust T cell response in mice.

Chapman R, Stutz H, Jacobs W Jr, Shephard E, Williamson AL.

PLoS One. 2013 Aug 20;8(8):e71601. doi: 10.1371/journal.pone.0071601. eCollection 2013.

8.

Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.

Turk G, Ghiglione Y, Falivene J, Socias ME, Laufer N, Coloccini RS, Rodriguez AM, Ruiz MJ, Pando MÁ, Giavedoni LD, Cahn P, Sued O, Salomon H, Gherardi MM.

J Virol. 2013 Jul;87(13):7445-62. doi: 10.1128/JVI.00865-13. Epub 2013 Apr 24.

9.

Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.

Chege GK, Burgers WA, Stutz H, Meyers AE, Chapman R, Kiravu A, Bunjun R, Shephard EG, Jacobs WR Jr, Rybicki EP, Williamson AL.

J Virol. 2013 May;87(9):5151-60. doi: 10.1128/JVI.03178-12. Epub 2013 Feb 28.

10.

A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe).

de Jose MI, Jiménez de Ory S, Espiau M, Fortuny C, Navarro ML, Soler-Palacín P, Muñoz-Fernandez MA; working groups of CoRISpe and HIV HGM BioBank.

BMC Infect Dis. 2013 Jan 2;13:2. doi: 10.1186/1471-2334-13-2.

11.

Fragmentation of SIV-gag vaccine induces broader T cell responses.

Benlahrech A, Meiser A, Herath S, Papagatsias T, Athanasopoulos T, Li F, Self S, Bachy V, Hervouet C, Logan K, Klavinskis L, Dickson G, Patterson S.

PLoS One. 2012;7(10):e48038. doi: 10.1371/journal.pone.0048038. Epub 2012 Oct 31.

12.

Evaluating cellular polyfunctionality with a novel polyfunctionality index.

Larsen M, Sauce D, Arnaud L, Fastenackels S, Appay V, Gorochov G.

PLoS One. 2012;7(7):e42403. doi: 10.1371/journal.pone.0042403. Epub 2012 Jul 30.

13.

FOXO3 regulates the CD8 T cell response to a chronic viral infection.

Sullivan JA, Kim EH, Plisch EH, Suresh M.

J Virol. 2012 Sep;86(17):9025-34. doi: 10.1128/JVI.00942-12. Epub 2012 Jun 6.

Supplemental Content

Support Center